- Cancer Biology & Biomarkers
- Chromatography & Mass Spectrometry
- Contract Research, Clinical Trials and Outsourcing
- Drug Discovery
- Drug Targets
- Flow Cytometry
- Informatics & Lab Automation
- Ingredients, Excipients and Dosages
- Microbiology & RMMs
- NIR, PAT & QbD
- Raman Spectroscopy
- Screening, Assays & High-Content Analysis
- Thermal Processing
- Events & Workshops
European Pharmaceutical Review Extra
The latest blogs, views and comments on the Pharma world from the leading experts in the industry…
Posted on: 4 February 2016 | Author: Victoria White, European Pharmaceutical Review
The Zika virus has taken hold in South America. Its possible link to microcephaly in newborn babies and neurological conditions has led the World Health Organization to declare a Public Health Emergency of International Concern. Here we discuss the virus, countermeasures and the race for a vaccine...
Posted on: 29 January 2016 | Author: Adewale Joseph Ogunleye, Adekunle Ajasin University, Akungba Akoko, Ondo State, Nigeria
This article explores how scientists are developing a fast, qualitative and specific technique for the detection and classification of microorganisms...
Posted on: 28 January 2016 | Author: Victoria White, Digital Content Producer, European Pharmaceutical Review
2015 was an interesting year for the pharmaceutical industry. Here we pick a selection of the top stories that hit the headlines...
Posted on: 19 January 2016 | Author: Snehal Chougule, Allied Market Research
Snehal Chougule discusses the ovarian cancer treatment market and recent approvals by the US Food and Drug Administration...
Posted on: 5 January 2016 | Author: Victoria White, European Pharmaceutical Review
A number of pharmaceutical companies see great potential in a universal flu vaccine, each hoping they will be the first to gain regulatory approval of their candidates. European Pharmaceutical Review spoke with Gregory Stoloff, CEO of one such company, SEEK, to find out more...
Posted on: 25 November 2015 | Author: Garry White, Chief Investment Commentator, Charles Stanley
Viagra maker Pfizer announced on Monday that it would purchase Allergan, the Irish maker of Botox, for about $160bn – the biggest deal ever in the healthcare sector. Could more mega-mergers be in prospect?
Posted on: 6 November 2015 | Author: Ashley Puscas, Associate Attorney at Laura Devine Attorneys
In our globalised economy, it is more common than ever to see pharma companies expanding to establish a presence in multiple markets. Here Ashley Puscas discusses the immigration pathways for pharma seeking to relocate or expand in the US...
Posted on: 22 October 2015 | Author: Caroline Rivett and Dr Cornelius Namiluko at KPMG
Dr Cornelius Namiluko and Caroline Rivett discuss cyber security in the pharmaceutical industry and the approaches companies can take to address the risk of a cyber attack...
Posted on: 20 October 2015 | Author: Victoria White
In the run up to ADHD Awareness Week, European Pharmaceutical Review spoke with Tom Croce, Head of Global Patient Advocacy at Shire, to find out more about the awards and what makes Shire a 'patient-centric' company...
Posted on: 18 November 2013 | Author: Dr Kevin Robinson
The response to a lack of skilled managers is often to take a ‘sticking plaster’ approach to the problem by deciding to take on one or two pricing managers and have them report into the commercial or finance team. Experience to date shows that this will have limited success, for a number of reasons...
Posted on: 5 November 2013 | Author: Dr Kevin Robinson
Few markets have undergone the degree of change experienced by the life sciences sector in recent years. The end of the blockbuster drug era, the increasing cost of product development and a growing population putting greater strain on healthcare services around the world have combined at a time when economic constraints are putting fierce pressures on the public purse to do more with less...
Posted on: 28 October 2013 | Author: Dr Kevin Robinson
End-users, be they patients or consumers, are taking a good look at the cardiovascular benefits of omega-3s … and tend to like what they see.
ABB Analytical Measurement ABL&E Group ADInstruments Ltd Analytik Jena AG Astell Scientific Ltd Axis-Shield Diagnostics Ltd Bachem AG Bio-Rad Laboratories Biopharma Group Black Swan Analysis Limited CAMO Software AS Celsis International ChemAxon Cherwell Laboratories CI Precision Cobalt Light Systems DiscoveRx Dotmatics Limited Edinburgh Instruments Enterprise System Partners EUROGENTEC HunterLab IDBS IONICON Analytik GmbH kbiosystems ltd L.B. Bohle Maschinen + Verfahren GmbH LabWare MKS Umetrics Nanosurf New England Biolabs, Inc. Panasonic Biomedical Sales Europe B.V. PerkinElmer Inc Portalis Ltd Powder Systems Limited (PSL) RADWAG ReAgent Source BioScience Spectrum®Labs.com Stratech Scientific Limited Takara Clontech Thermal Detection Ltd. Tuttnauer Vaisala Ltd VIAVI OSP Waters Corporation Wickham Laboratories Limited Xylem Analytics YMC Europe GmbH Ytron-Quadro (UK) Limited Yusen Logistics